A Twist in the Delaware Two-Step: A Proposed Amendment to the Delaware General Corporation Law Would Eliminate Required Stockholder Vote

A two-step merger is a common acquisition structure for public company sale transactions.  Under this structure, the buyer commences a tender or exchange offer to obtain over 50% of the target’s voting shares, followed by a second-step merger to acquire the remaining voting shares.  Generally speaking, unless the buyer obtains 90% or more of the target’s voting shares in the first-step tender or exchange offer (or through exercising a "top-up option," if any), the target’s stockholders must vote to approve the second-step merger.  This stockholder vote requires a proxy statement or an information statement to be delivered to the target’s stockholders, which can be onerous.

Continue Reading

LINKEDIN WOULD LIKE TO ADD YOU TO ITS PROFESSIONAL NETWORK; DO YOU WANT TO ACCEPT?

Professional networking giant LinkedIn is courting investors in advance of its IPO, but its dual-class share structure gives cause for consideration.  No stranger to media heavyweights, including Facebook, Google, the Washington Post and the New York Times, a dual-class share structure is touted by some for its benefits, including the ability of controlling shareholders to:

•    protect corporate culture;

•    avoid the short-sightedness of quarterly performance expectations; and

•    thwart hostile takeovers.

But shareholders have cried foul in the past.  After a federal court struck down the SEC’s attempt to prohibit dual-class share structures in the late 1980s, the stock exchanges took matters into their own hands with rules forbidding exchange-listed companies from adopting a dual-class share structure.  The glaring loophole, however, remains: a company with an existing dual-class share structure can list its shares.

Continue Reading

POISON PILL UPHELD BY DELAWARE CHANCERY COURT

The Delaware Chancery Court upheld Airgas, Inc.'s poison pill defense in a ruling on Feb. 15, 2011 (PDF).  The Airgas poison pill had blocked a $5.9 billion hostile bid from Air Products & Chemicals Inc., which dropped the bid following the ruling.

As reported by The Wall Street Journal today, the Delaware court ruled that the “power to defeat an inadequate hostile tender offer ultimately lies with the board of directors.”  The court held that the poison pill was a reasonable response to the Air Products’ takeover attempt.  The key is that the court found the Airgas board of directors to be acting in good faith and complying with its fiduciary duties.

Bloomberg Businessweek reported today that the Air Products’ offer, which was made public on Feb. 4, 2010, was the eighth-longest-running U.S. hostile takeover bid since Bloomberg started tracking takeover offers.  Airgas subsequently announced a $300 million share buyback.

OUR TAKE:  This was an anticipated decision because poison pill cases are typically settled or dropped before the cases can be decided.  The Chancery Court has reinforced the viability of a poison pill as an appropriate response to a hostile bid that a board of directors in good faith believes is inadequate.